EUVIMEDEUVIMED entdecken
Crossref

Disrupting oncogenic signaling in triple negative breast cancer: The interplay of Cx43, Pyk2, and Src in MDA-MB-231 cells

Li Zheng, Gaelle Spagnol, Paras Gupta, Paul L Sorgen

Cell and Tissue Research · 2026

DOI: 10.1007/s00441-026-04074-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell and Tissue Research, 2026. Verfasst von Li Zheng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, 68198, USA. Hauptthemen laut MEDLINE: Focal Adhesion Kinase 2, Triple Negative Breast Neoplasms, Signal Transduction, src-Family Kinases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 104 Literaturangaben. Gefördert von: NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple-negative breast cancer (TNBC) lacks targeted therapies and is driven by dysregulated signaling networks that promote migration, invasion, and survival. Connexin43 (Cx43), a gap junction protein essential for maintaining normal mammary epithelial homeostasis, becomes aberrantly phosphorylated and mislocalized in breast cancer, contributing to disease progression. Because the tyrosine kinases Pyk2 and Src regulate Cx43 and multiple pro-tumorigenic pathways, we investigated whether their combined inhibition could suppress malignant behaviors in TNBC. In MDA-MB-231 cells, the Pyk2 inhibitor PF4618433 and Src inhibitor Saracatinib modestly reduced metabolic activity at high concentrations; however dual treatment produced a dose-dependent and synergistic reduction in viability. In migration and invasion assays, each inhibitor reduced motility, however dual inhibition produced the strongest suppression. Cx43 knockdown impaired baseline migration and invasion and altered the response to Pyk2/Src inhibition, indicating that Cx43 modulates sensitivity to these agents. PF4618433 increased Cx43 plaque formation without changing total protein levels. Mechanistically, Pyk2 inhibition reduced phosphorylation of Cx43 at Y265 and decreased levels of TAZ, p-Erk1/2, p130Cas, and Notch1, whereas Src inhibition only reduced p-Erk1/2. Dual treatment did not further decrease these signaling nodes but nonetheless produced stronger functional inhibition of viability and motility, and the shared regulation of p-Erk1/2 by Pyk2 and Src may help explain how compensatory Pyk2 activation limits the effectiveness of Src-targeted therapies. Together, these findings show that coordinated Pyk2 and Src inhibition restores Cx43 organization and disrupts multiple malignant traits in TNBC cells, supporting this combination as a promising therapeutic strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Focal Adhesion Kinase 2Triple Negative Breast NeoplasmsSignal Transductionsrc-Family KinasesConnexin 43HumansFemaleMDA-MB-231 CellsCell MovementBenzodioxolesPhosphorylationNeoplasm InvasivenessTyrosine Kinase InhibitorsProtein Kinase InhibitorsQuinazolines

Stichwörter der Autor:innen

Breast cancerCx43PhosphorylationPyk2Src

Substanzen

Focal Adhesion Kinase 2src-Family KinasesConnexin 43saracatinibBenzodioxolesPTK2B protein, humanTyrosine Kinase InhibitorsProtein Kinase InhibitorsQuinazolines

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
  • Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, 68198, USA. psorgen@unmc.edu.

Förderung

  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Zheng, L., Spagnol, G., Gupta, P., & Sorgen, P. L. (2026). Disrupting oncogenic signaling in triple negative breast cancer: The interplay of Cx43, Pyk2, and Src in MDA-MB-231 cells. Cell and Tissue Research. https://doi.org/10.1007/s00441-026-04074-5

Vancouver

Zheng L, Spagnol G, Gupta P, Sorgen PL. Disrupting oncogenic signaling in triple negative breast cancer: The interplay of Cx43, Pyk2, and Src in MDA-MB-231 cells. Cell and Tissue Research. 2026. doi:10.1007/s00441-026-04074-5

BibTeX
@article{Zheng2026,
  author = {Zheng, Li and Spagnol, Gaelle and Gupta, Paras and Sorgen, Paul L},
  title = {Disrupting oncogenic signaling in triple negative breast cancer: The interplay of Cx43, Pyk2, and Src in MDA-MB-231 cells},
  journal = {Cell and Tissue Research},
  year = {2026},
  doi = {10.1007/s00441-026-04074-5}
}
Kostenlos starten →